Bensler’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-6,910
Closed -$3.67M 168
2023
Q4
$3.67M Buy
6,910
+928
+16% +$449K 0.61% 53
2023
Q3
$3.03M Buy
5,982
+455
+8% +$242K 0.58% 57
2023
Q2
$2.88M Buy
5,527
+169
+3% +$91.2K 0.55% 64
2023
Q1
$3.09M Buy
5,358
+309
+6% +$174K 0.62% 54
2022
Q4
$2.78M Buy
5,049
+122
+2% +$64.6K 0.62% 58
2022
Q3
$2.5M Buy
4,927
+145
+3% +$81.1K 0.6% 59
2022
Q2
$2.6M Buy
4,782
+281
+6% +$155K 0.62% 55
2022
Q1
$2.66M Buy
4,501
+310
+7% +$178K 0.56% 61
2021
Q4
$2.8M Buy
+4,191
New +$2.62M 0.78% 49

Other funds holding TMO

Bensler's TMO Position: Q1 2024 in Review

Bensler sold out of Thermo Fisher Scientific (TMO) in Q1 2024, closing a stake of 6,910 shares — an estimated $3.67M sold.

Bensler first reported a position in TMO in Q4 2021 and held it in 9 quarters. The position peaked at $3.67M in Q4 2023. 2,527 funds tracked by Wall St. Rank hold TMO as of Q1 2024.

  • Bensler reported no remaining Thermo Fisher Scientific position as of Q1 2024 after selling out during the quarter.
  • Bensler sold 6,910 Thermo Fisher Scientific shares in Q1 2024, an estimated $3.67M.
  • Bensler first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 9 quarters.
  • Bensler's Thermo Fisher Scientific position peaked at $3.67M in Q4 2023.
  • 2,527 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.

Based on Bensler's 13F filing for Q1 2024, filed 30 Apr 2024.